J Korean Ophthalmol Soc > Volume 54(12); 2013 > Article
Journal of the Korean Ophthalmological Society 2013;54(12):1945-1949.
DOI: https://doi.org/10.3341/jkos.2013.54.12.1945    Published online December 13, 2013.
A Case of Acute Anterior Uveitis Associated with HLA-B27 Positivity after Intravitreal Injection of Bevacizumab.
Jang Won Seo, Yoon Hyung Kwon
Department of Ophthalmology, Dong-A University College of Medicine, Busan, Korea. yhkwon@dau.ac.kr
유리체내 베바시주맙 주사술 후 발생한 HLA‐B27 양성 급성 전방 포도막염 1예
서장원⋅권윤형
Department of Ophthalmology, Dong-A University College of Medicine, Busan, Korea
Abstract
PURPOSE
Intravitreal injection of bevacizumab (Avastin(R)) can lead to several intraocular complications including endophthalmitis, hemorrhage and inflammation. We present one case of acute anterior uveitis with hypopyon in an HLA-B27(+) patient following intravitreal injection of bevacizumab. CASE SUMMARY: A 40-year-old male with known central retinal vein occlusion presented with redness and decreased visual acuity in the left eye. Symptoms had developed 4 days earlier after the sixth intravitreal injection of bevacizumab in that eye. The patient had a marked anterior chamber reaction with hypopyon and posterior synechiae. Nine days after onset, similar symptoms in the left eye occurred in the uninjected right eye. Through examination and clinical manifestations, we diagnosed acute anterior uveitis associated with HLA-B27 positivity. The patient was treated with 1% prednisolone acetate, 0.5% moxifloxacin and 1% atropine in both eyes and all symptoms had resolved after 6 weeks.
Key Words: Acute anterior uveitis;Bevacizumab;HLA-B27 positive;Hypopyon;Intravitreal injection


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next